Updates are available Correction dated 2016-05-09

Click to view Correction: https://doi.org/10.1186/s12977-016-0264-y

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s12977-016-0251-3

Published Online: 2016-04-01

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark